Mazor Robotics LTD (MZOR) Share Value Rose While Biondo Investment Advisors Has Increased Stake; Clean Yield Group Decreased Its Stake in Hcp Com (HCP) by $402,705

February 14, 2018 - By Marie Mckinney

Biondo Investment Advisors Llc increased its stake in Mazor Robotics Ltd (MZOR) by 221.36% based on its latest 2017Q3 regulatory filing with the SEC. Biondo Investment Advisors Llc bought 43,210 shares as the company’s stock rose 90.63% with the market. The institutional investor held 62,730 shares of the medical and dental instruments company at the end of 2017Q3, valued at $3.10 million, up from 19,520 at the end of the previous reported quarter. Biondo Investment Advisors Llc who had been investing in Mazor Robotics Ltd for a number of months, seems to be bullish on the $1.51 billion market cap company. The stock increased 0.83% or $0.49 during the last trading session, reaching $59.7. About 849,513 shares traded or 60.34% up from the average. Mazor Robotics Ltd. (NASDAQ:MZOR) has risen 206.35% since February 14, 2017 and is uptrending. It has outperformed by 189.65% the S&P500.

Clean Yield Group decreased its stake in Hcp Inc Com (HCP) by 55.38% based on its latest 2017Q3 regulatory filing with the SEC. Clean Yield Group sold 14,915 shares as the company’s stock rose 2.09% with the market. The institutional investor held 12,015 shares of the consumer services company at the end of 2017Q3, valued at $334,000, down from 26,930 at the end of the previous reported quarter. Clean Yield Group who had been investing in Hcp Inc Com for a number of months, seems to be less bullish one the $10.33 billion market cap company. The stock decreased 2.63% or $0.59 during the last trading session, reaching $21.84. About 3.55 million shares traded. HCP, Inc. (NYSE:HCP) has risen 8.01% since February 14, 2017 and is uptrending. It has underperformed by 8.69% the S&P500.

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.38, from 1.23 in 2017Q2. It dropped, as 54 investors sold HCP shares while 188 reduced holdings. 43 funds opened positions while 163 raised stakes. 411.39 million shares or 0.00% less from 411.39 million shares in 2017Q2 were reported. Ww Asset Management Incorporated owns 48,716 shares for 0.04% of their portfolio. Netherlands-based Bedrijfstakpensioenfonds Voor De Media Pno has invested 0.13% in HCP, Inc. (NYSE:HCP). Macroview Invest Mngmt Ltd Co invested in 227 shares. Cypress Group accumulated 19,150 shares. Neuberger Berman Lc has invested 0% in HCP, Inc. (NYSE:HCP). 965 were accumulated by First Interstate Bancshares. Apg Asset Mgmt Us reported 3.90M shares stake. Gateway Inv Advisers Limited Liability Corp owns 28,602 shares. Tudor Invest Et Al, a Connecticut-based fund reported 52,623 shares. Keybank Natl Association Oh invested in 38,239 shares. Sumitomo Life Ins holds 39,775 shares or 0.14% of its portfolio. Cleararc Cap has 12,034 shares for 0.05% of their portfolio. Kings Point Mgmt invested in 0.05% or 7,535 shares. Tiaa Cref Management Lc has invested 0.04% in HCP, Inc. (NYSE:HCP). Texas Permanent School Fund reported 129,964 shares.

Among 20 analysts covering HCP (NYSE:HCP), 5 have Buy rating, 1 Sell and 14 Hold. Therefore 25% are positive. HCP had 71 analyst reports since September 8, 2015 according to SRatingsIntel. On Tuesday, August 1 the stock rating was maintained by BMO Capital Markets with “Hold”. The firm earned “Neutral” rating on Wednesday, August 24 by Citigroup. The stock of HCP, Inc. (NYSE:HCP) earned “Hold” rating by Stifel Nicolaus on Thursday, November 2. The firm earned “Neutral” rating on Tuesday, October 4 by Bank of America. The stock of HCP, Inc. (NYSE:HCP) has “Neutral” rating given on Wednesday, March 16 by UBS. As per Monday, September 11, the company rating was maintained by RBC Capital Markets. Goldman Sachs downgraded HCP, Inc. (NYSE:HCP) on Monday, September 21 to “Sell” rating. BMO Capital Markets maintained HCP, Inc. (NYSE:HCP) rating on Monday, October 16. BMO Capital Markets has “Hold” rating and $28.0 target. The stock of HCP, Inc. (NYSE:HCP) earned “Hold” rating by KeyBanc Capital Markets on Monday, October 16. The rating was initiated by Raymond James with “Underperform” on Tuesday, July 26.

Among 7 analysts covering Mazor Robotics (NASDAQ:MZOR), 2 have Buy rating, 2 Sell and 3 Hold. Therefore 29% are positive. Mazor Robotics had 16 analyst reports since November 20, 2015 according to SRatingsIntel. The stock of Mazor Robotics Ltd. (NASDAQ:MZOR) earned “Outperform” rating by Wells Fargo on Thursday, May 19. Barclays Capital maintained the stock with “Overweight” rating in Thursday, July 14 report. The stock of Mazor Robotics Ltd. (NASDAQ:MZOR) has “Hold” rating given on Wednesday, August 2 by Needham. Standpoint Research initiated Mazor Robotics Ltd. (NASDAQ:MZOR) rating on Friday, July 8. Standpoint Research has “Buy” rating and $30 target. B. Riley & Co initiated Mazor Robotics Ltd. (NASDAQ:MZOR) on Friday, October 7 with “Buy” rating. The firm earned “Hold” rating on Thursday, October 5 by Needham. The firm has “Sell” rating given on Thursday, October 19 by Barclays Capital. The firm has “Hold” rating by Needham given on Thursday, July 6. Ladenburg maintained the stock with “Buy” rating in Monday, October 30 report. The company was upgraded on Friday, November 20 by Sterne Agee CRT.

Biondo Investment Advisors Llc, which manages about $423.40M and $363.57M US Long portfolio, decreased its stake in Core Laboratories N V (NYSE:CLB) by 5,210 shares to 38,427 shares, valued at $3.79 million in 2017Q3, according to the filing. It also reduced its holding in Amgen Inc (NASDAQ:AMGN) by 6,085 shares in the quarter, leaving it with 6,075 shares, and cut its stake in Nxp Semiconductors N V (NASDAQ:NXPI).

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>